ID

44270

Descripción

Dietary Protein and Insulin Sensitivity Study; ODM derived from: https://clinicaltrials.gov/show/NCT00508937

Link

https://clinicaltrials.gov/show/NCT00508937

Palabras clave

  1. 8/5/18 8/5/18 -
  2. 20/9/21 20/9/21 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Insulin Resistance NCT00508937

Eligibility Insulin Resistance NCT00508937

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
body mass index (bmi) ≥ 27 and ≤ 40 kg/m2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
homa-ir ≥ 2.5
Descripción

Homeostasis model assessment Insulin Resistance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1829779
UMLS CUI [1,2]
C0021655
non-smoking
Descripción

Non-smoker

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0337672
total cholesterol and ldl cholesterol <95th percentile for sex and age
Descripción

Serum total cholesterol measurement | Serum LDL cholesterol measurement | Gender | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1445957
UMLS CUI [2]
C0428474
UMLS CUI [3]
C0079399
UMLS CUI [4]
C0001779
fasting triglycerides < 500mg/dl
Descripción

Serum fasting triglyceride measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0582824
fasting blood sugar < 126
Descripción

Fasting Blood Sugar Measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2825162
urinary microalbumin < 30 mg/l
Descripción

Urinary Microalbumin Assay

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2981750
normal thyroid stimulating hormone levels
Descripción

Serum TSH level normal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0580433
hematocrit ≥ 36%
Descripción

Hematocrit procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018935
blood pressure < 150/90
Descripción

Blood pressure measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005824
at least 3 months of a weight-stable state (± 5 lbs) prior to the study. during the study, subjects will be required to maintain their body weight within ± 3% (up to a maximum change of 5 lbs) of their initial weight over the course of any consecutive two weeks after the second week of baseline diet or during the last week of each diet phase
Descripción

Stable body weight | Requirement Body Weight Maintenance | Diet

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0517386
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C4042910
UMLS CUI [3]
C0012155
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of coronary heart disease, cerebrovascular disease, peripheral vascular disease, bleeding disorder, liver or renal disease, diabetes, lung disease, hiv, or cancer (other than skin cancer) in the last 5 years
Descripción

Coronary heart disease | Cerebrovascular Disorder | Peripheral Vascular Disease | Blood Coagulation Disorders | Liver disease | Kidney Disease | Diabetes Mellitus | Lung disease | HIV Infection | Malignant Neoplasms | Exception Skin carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0010068
UMLS CUI [2]
C0007820
UMLS CUI [3]
C0085096
UMLS CUI [4]
C0005779
UMLS CUI [5]
C0023895
UMLS CUI [6]
C0022658
UMLS CUI [7]
C0011849
UMLS CUI [8]
C0024115
UMLS CUI [9]
C0019693
UMLS CUI [10]
C0006826
UMLS CUI [11,1]
C1705847
UMLS CUI [11,2]
C0699893
use of drugs known to affect lipid metabolism or insulin resistance, hormones, or the blood thinning agent, warfarin
Descripción

Pharmaceutical Preparations Affecting Lipid Metabolism | Pharmaceutical Preparations Affecting Insulin Resistance | Hormone preparation | Anticoagulants | Warfarin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0598783
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0021655
UMLS CUI [3]
C0019932
UMLS CUI [4]
C0003280
UMLS CUI [5]
C0043031
use of alcohol or dietary supplements during the study
Descripción

Alcohol consumption | Dietary Supplements

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001948
UMLS CUI [2]
C0242295
pregnancy
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961

Similar models

Eligibility Insulin Resistance NCT00508937

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Body mass index
Item
body mass index (bmi) ≥ 27 and ≤ 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Homeostasis model assessment Insulin Resistance
Item
homa-ir ≥ 2.5
boolean
C1829779 (UMLS CUI [1,1])
C0021655 (UMLS CUI [1,2])
Non-smoker
Item
non-smoking
boolean
C0337672 (UMLS CUI [1])
Serum total cholesterol measurement | Serum LDL cholesterol measurement | Gender | Age
Item
total cholesterol and ldl cholesterol <95th percentile for sex and age
boolean
C1445957 (UMLS CUI [1])
C0428474 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
Serum fasting triglyceride measurement
Item
fasting triglycerides < 500mg/dl
boolean
C0582824 (UMLS CUI [1])
Fasting Blood Sugar Measurement
Item
fasting blood sugar < 126
boolean
C2825162 (UMLS CUI [1])
Urinary Microalbumin Assay
Item
urinary microalbumin < 30 mg/l
boolean
C2981750 (UMLS CUI [1])
Serum TSH level normal
Item
normal thyroid stimulating hormone levels
boolean
C0580433 (UMLS CUI [1])
Hematocrit procedure
Item
hematocrit ≥ 36%
boolean
C0018935 (UMLS CUI [1])
Blood pressure measurement
Item
blood pressure < 150/90
boolean
C0005824 (UMLS CUI [1])
Stable body weight | Requirement Body Weight Maintenance | Diet
Item
at least 3 months of a weight-stable state (± 5 lbs) prior to the study. during the study, subjects will be required to maintain their body weight within ± 3% (up to a maximum change of 5 lbs) of their initial weight over the course of any consecutive two weeks after the second week of baseline diet or during the last week of each diet phase
boolean
C0517386 (UMLS CUI [1])
C1514873 (UMLS CUI [2,1])
C4042910 (UMLS CUI [2,2])
C0012155 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Coronary heart disease | Cerebrovascular Disorder | Peripheral Vascular Disease | Blood Coagulation Disorders | Liver disease | Kidney Disease | Diabetes Mellitus | Lung disease | HIV Infection | Malignant Neoplasms | Exception Skin carcinoma
Item
history of coronary heart disease, cerebrovascular disease, peripheral vascular disease, bleeding disorder, liver or renal disease, diabetes, lung disease, hiv, or cancer (other than skin cancer) in the last 5 years
boolean
C0010068 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
C0085096 (UMLS CUI [3])
C0005779 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
C0022658 (UMLS CUI [6])
C0011849 (UMLS CUI [7])
C0024115 (UMLS CUI [8])
C0019693 (UMLS CUI [9])
C0006826 (UMLS CUI [10])
C1705847 (UMLS CUI [11,1])
C0699893 (UMLS CUI [11,2])
Pharmaceutical Preparations Affecting Lipid Metabolism | Pharmaceutical Preparations Affecting Insulin Resistance | Hormone preparation | Anticoagulants | Warfarin
Item
use of drugs known to affect lipid metabolism or insulin resistance, hormones, or the blood thinning agent, warfarin
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0598783 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0021655 (UMLS CUI [2,3])
C0019932 (UMLS CUI [3])
C0003280 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
Alcohol consumption | Dietary Supplements
Item
use of alcohol or dietary supplements during the study
boolean
C0001948 (UMLS CUI [1])
C0242295 (UMLS CUI [2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial